Impact of Increased Duration of Trimethoprim-Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia After Renal Transplant

BACKGROUND: Trimethoprim-sulfamethoxazole (TMP-SMX) is recommended as prophylaxis against Pneumocystis pneumonia (PCP) in renal transplant recipients. The optimal duration of prophylaxis is unknown. Longer duration of prophylaxis may increase the risk of adverse effects. The aim of this retrospectiv...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transplant
Autors principals: Chapman, Fiona A., Dickerson, Jonathan E., Daly, Conal, Clancy, Marc, Geddes, Colin
Format: Artigo
Idioma:Inglês
Publicat: International Scientific Literature, Inc. 2019
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6918803/
https://ncbi.nlm.nih.gov/pubmed/31806862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AOT.918195
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars